Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma

Clinical trial NCT06903117 · RECRUITING

Trial details

NCT number: NCT06903117
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Lung Cancer

Start date: 2025-03-24
Primary completion: 2027-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.